Asymmetrex Intensifies Value of Counting Adult Stem Cells

In Upcoming Webinar and Conferences, Asymmetrex Will Intensify Education on Counting Adult Tissue Stem Cells For Regenerative Medicine and Drug Development As 2015 drew to a close, stem cell medicine biotechnology start-up company Asymmetrex began an effort to educate the pharmaceutical and regenerative medicine industries on the value of counting adult tissue stem cells. The

March 2, 2016

Moving on to a Future of Counting Adult Tissue Stem Cells

With its recently described improved technologies for specifically identifying adult tissue stem cells  or detecting their function by a computer simulation technology, biotech start-up Asymmetrex is anticipating a need for rules to move the field of stem cell biology from a past of common errors and misconceptions to a future of exact quantification. Asymmetrex’s  5

February 5, 2016